alzheimerstreatments.com

modafinil.info

modafinil is a safe stimulant

http://www.modafinil.info/modafinil-stimulant-3.htm

Lyons TJ, French J. Headquarters USAF Human Systems Division,. Brooks Air Force Base, TX 78235. Aviat Space Environ Med. Successful treatment of hypersomnia and narcolepsy. Drug of choice for narcolepsy. In the treatment of. And naps as counter measures in sleep. As a treatment for excessive daytime sleep. Use in a sleep deprivation experiment. Excessive sleepiness in Parkinson's disease. The unique properties of a new stimulant. For sustaining the alertness of helicopter pilots.

smart-nutrition.net

Galantamine info, articles, Alzheimer's research

http://www.smart-nutrition.net/galantamine-info.htm

Its use in Alzheimer's. Benefits to Alzheimer's patients. A study in Alzheimer's. Its effects on Alzheimer's. Therapeutic effects beyond cognitition. Nicotinic receptors and Alzheimer's. A new treatment for Alzheimer's. Nicotinic receptors in Alzheimer's. Effect on nicotinic receptor binding. An allosterically potentiating ligant. Nicotinic modulation in older rabbits. Effect on memory and nicotinic receptors. A 6 month Alzheimer's study.

pikamilon.com

pikamilon is used as a tranquilizer

http://www.pikamilon.com/pikamilon/pikamilon-3.htm

The results of clinical study of the drug Pikamilon. Analysis of data of neurologic and psychiatric clinics). A P Huaichenko, R.P. Kruglikova-Lvova. Without the sedative component and myorelaxation; Pikamilon is recommended for asthenic disorders within the limits of different psychical diseases and for treating depressions.

modafinil.info

modafinil is devoid of short-term side-effects

http://www.modafinil.info/modafinil-growthhormone-10.htm

Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation. Brun J; Chamba G; Khalfallah Y; Girard P;. Boissy I; Bastuji H; Sassolas G; Claustrat B. Service de Radiopharmacie et Radioanalyse,. Centre de Medecine Nucleaire,. Hopital NeuroCardiologique, Lyon, France. 1998 Jun; 7(2): 105-14. Successful treatment of hypersomnia and narcolepsy. Drug of choice for narcolepsy. In the treatment of.

deprenyl.net

Selegiline delays the onset of disability in Parkinsonian patients

http://www.deprenyl.net/parkinsons/deprenyl-parkinsons-9.htm

Selegiline delays the onset of disability in de novo Parkinsonian patients. Swedish Parkinson Study Group. Palhagen S, Heinonen EH, Hagglund J, Kaugesaar T,. Kontants H, Maki-Ikola O, Palm R, Turunen J. Department of Neurology,. Ryhov Hospital, Jonkoping, Sweden. OBJECTIVE: The objective of this study was to investigate the effect of selegiline first as monotherapy and then in combination with levodopa in the early phase of PD. Total and motor scores; p 0.001). Selegiline had a wash-in effect (i&...Simil...

deprenyl.net

Deprenyl helps people quit smoking by raising dopamine levels

http://www.deprenyl.net/deprenyl/deprenyl-58.htm

Effects of selegiline (l-deprenyl) during smoking and short-term abstinence. Houtsmuller EJ, Thornton JA, Stitzer ML. Behavioral Pharmacology Research Unit. Johns Hopkins University School of Medicine. 5510 Nathan Shock Drive,. Baltimore, MD 21224-6823, USA ehoutsm@jhmi.edu. Berl) 2002 Sep;163(2):213-20. OBJECTIVES. To examine the effects of the selective MAO-B inhibitor selegiline on withdrawal symptoms, smoking behavior and smoking satisfaction ratings. RESULTS. Selegiline decreased craving, especi...

deprenyl.net

Deprenyl - sexual performance and longevity

http://deprenyl.net/deprenyl/deprenyl-43.htm

Sexual performance and longevity. Department of Pharmacology,. Semmelweis University of Medicine,. In the treatment of Alzheimer's. MAO-B inhibitors in the treatment of Alzheimer's. Stimulates biosynthesis of cytokines interleukin-1 & 6. And age-related decline of the striatal dopaminergic system. Improves memory in amnesic Alzheimer's. Treatment of behavioral symptoms of Alzheimer's. Increases life span in Parkinson'. Possible mechanisms of action in Parkinson's. Management of early Parkinson's. Effects...

deprenyl.net

History of deprenyl

http://www.deprenyl.net/deprenyl/deprenyl-1.htm

The first selective inhibitor of monoamine oxidase type B. Semmelweis University of Medicine. 1997 Nov, 436, 482-93. In the treatment of Alzheimer's. MAO-B inhibitors in the treatment of Alzheimer's. Stimulates biosynthesis of cytokines interleukin-1 & 6. And age-related decline of the striatal dopaminergic system. Improves memory in amnesic Alzheimer's. Treatment of behavioral symptoms of Alzheimer's. Increases life span in Parkinson'. Possible mechanisms of action in Parkinson's. Is an MAO-B inhibitor.

deprenyl.net

deprenyl antidepressant efficacy

http://www.deprenyl.net/deprenyl/deprenyl-4.htm

A controlled study of the antidepressant efficacy and side effects of (-)deprenyl. A selective monoamine. Mann JJ, Aarons SF, Wilner PJ, Keilp JG, Sweeney JA,. Pearlstein T, Frances AJ, Kocsis JH, Brown RP. Department of Psychiatry,. Cornell University Medical College,. New York, NY 10021. 1989 Jan; 46(1):45-50 1991; 136:91-4. In a dose range where it is distinguished by the absence of many of the side effects typical of nonselective MAO inhibitors.